[Advances in pulmonology].

Factors influencing adrenocortical suppression during long-term triamcinolone acetonide therapy in asthma. Ann Allergy (1980) 1.05

Assessment of adrenocortical function in asthmatic patients on long-term triamcinolone acetonide treatment. Ann Allergy (1979) 1.00

[Effect of long-term triamcinolone acetonide treatment on the neuromuscular system]. Pneumonol Pol (1982) 0.99

Interstitial lung disease in systemic sclerosis: comparison of BALF lymphocyte phenotype and DLCO impairment. Respir Med (1998) 0.82

Binding of dexamethasone and its effect on histamine release from rat mast cells. Int J Immunopharmacol (1988) 0.81

Urethral stricture as unusual complications of Wegener's granulomatosis. Neth J Med (1995) 0.80

Lymphocyte phenotyping in systemic sclerosis: a flow cytometry analysis of lymphocytes in bronchoalveolar lavage fluid. Anal Quant Cytol Histol (1997) 0.80

Changes in plasma high density lipoproteins (HDL) levels after salbutamol. Int J Clin Pharmacol Ther Toxicol (1985) 0.80

Comparison of oral prednisolone and intramuscular depot triamcinolone in patients with severe chronic asthma. Thorax (1985) 0.79

[Effect continuous positive airway pressure (CPAP) on left ventricular diastolic function in patients with obstructive sleep apnea syndrome--OSAS]. Pol Arch Med Wewn (1995) 0.78

Creatine kinase (CK) and creatine kinase isoenzyme (CK-MB) activity in serum before and after intravenous salbutamol administration of patients with bronchial asthma. Int J Clin Pharmacol Ther Toxicol (1992) 0.78

Flow cytometric evaluation of lymphocyte subpopulations in BALF of healthy smokers and nonsmokers. Folia Histochem Cytobiol (1999) 0.78

[Electrocardiographic changes in patients with airway obstruction]. Pol Arch Med Wewn (1992) 0.78

Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo. Am Heart J (2001) 0.78

Cardiac arrhythmias as a result of intravenous infusions of theophylline in patients with airway obstruction. Int J Clin Pharmacol Ther (1995) 0.77

T-cell subtypes in bronchoalveolar lavage fluid and in peripheral blood from patients with primary lung cancer. Diagn Cytopathol (2001) 0.77

Allergy to fish in fish meal factory workers. Int Arch Occup Environ Health (1981) 0.77

Diurnal blood pressure rhythm and urinary catecholamine excretion in obstructive sleep apnoea and essential hypertension. J Hypertens Suppl (1993) 0.75

[Bronchial asthma - is the hypothesis of adrenergic beta receptor blockade obsolete?]. Pol Arch Med Wewn (1981) 0.75

[Effect of furfural on the respiratory system]. Med Pr (1984) 0.75

Comparative studies on bronchospirometry under general and local anesthesia. Pol Med J (1968) 0.75

[Respiratory tract function in workers cleaning mazut-fired boilers]. Pneumonol Pol (1979) 0.75

[Effect of disodium cromoglycate (Intal) inhalation on airway patency]. Pol Arch Med Wewn (1982) 0.75

[Role of intal in the reduction of corticosteroid doses in the treatment of bronchial asthma and chronic spastic bronchitis]. Pneumonol Pol (1982) 0.75

[A case of subtotal resection of the small intestine]. Pol Arch Med Wewn (1970) 0.75

[Report on International Symposium on chloramphenicol-thiamphenicol, Jan 11-13 at Sils, Switzerland]. Pol Arch Med Wewn (1973) 0.75

[Phagocytic activity of the peripheral blood granulocytes in patients treated with triamcinolone acetonide and vitamin C]. Pneumonol Pol (1982) 0.75

[Advances in pneumonology. Aspirin-induced asthma]. Pol Arch Med Wewn (1975) 0.75

[Advances in pulmonology. Cyclic AMP, GMP, prostaglandins and bronchial asthma]. Pol Arch Med Wewn (1975) 0.75

[Advances in pulmonology]. Pol Arch Med Wewn (1967) 0.75

[Beclomethasone dipropionate -becotide) aerosol in the treatment of asthma and spastic bronchitis]. Pneumonol Pol (1976) 0.75

[Usefulness of atenolol in the treatment of patients with chronic bronchitis or bronchial asthma]. Pol Arch Med Wewn (1983) 0.75

[Effect of triamcinolone acetonide on the phagocytic capacity of isolated human peripheral granulocytes]. Pol Arch Med Wewn (1983) 0.75

[Advances in pulmonology. Dinatrium cromoglicum in the treatment of asthma]. Pol Arch Med Wewn (1972) 0.75

[Definition and classification of diseases associated with diffuse constriction of the lower respiratory tract]. Pol Arch Med Wewn (1966) 0.75

[Evaluation of Euphylline-retard based on the measurement of theophylline concentration in the blood serum and spirometric parameters]. Pneumonol Pol (1981) 0.75

[Advances in pulmonology. Drug-induced lung diseases]. Pol Arch Med Wewn (1974) 0.75

[Sodium cromoglycate (Intal) in the treatment of pollen-induced rhinitis]. Otolaryngol Pol (1981) 0.75

[Intal in the treatment of asthma. II. Clinical evaluation in relation to IgE serum level, peripheral blood eosinophils and determinations of peak respiratory flow]. Pol Arch Med Wewn (1978) 0.75

[Antibiotics]. Pieleg Polozna (1970) 0.75

The effect of triamcinolone acetonide on the phagocytosis by human polymorphonuclear leukocytes. Int J Clin Pharmacol Ther Toxicol (1982) 0.75

[(Intal (disodium cromoglycate) in the treatment of hay fever and vasomotor rhinitis]. Otolaryngol Pol (1979) 0.75

[Long-term corticosteroid treatment of bronchial asthma and chronic bronchitis]. Pol Arch Med Wewn (1972) 0.75

[Pleural biopsy]. Pol Arch Med Wewn (1975) 0.75

[Adrenal cortex function in bronchial asthma or asthmatic syndromes treated with betamethasone dépôt (Diprophos)]. Pneumonol Pol (1982) 0.75

[Corticoid therapy of allergic rhinitis]. Pneumonol Pol (1982) 0.75

Investigations on the role of acetylcholine esterase in hypersensitivity states. Acta Med Pol (1975) 0.75

[Pulmonary emphysema and alpha 1 -antitrypsin deficiency. Alpha 1 -antitrypsin, its characteristics and occurrence]. Pol Arch Med Wewn (1972) 0.75

[Disodium cromoglycate (Intal) after 10 years]. Pol Arch Med Wewn (1977) 0.75

[Inhalatory test provoked with prostaglandin F-2 alpha in patients with pollenosis]. Pol Arch Med Wewn (1977) 0.75

[Advances in pulmonology. Lung diseases caused by hypersensitivity to inhaled organic dust]. Pol Arch Med Wewn (1970) 0.75

Investigations on the role of acetylcholine esterase in hypersensitivity states. I. Acetylcholine esterase activity in respiratory system in experimental sensitization. Acta Med Pol (1974) 0.75

Investigations on the role of acetylcholine esterase in hypersensitivity states. II. Prostigmine provocation test in patients with bronchial asthma. Acta Med Pol (1974) 0.75

[Advantages and disadvantages of immunotherapy in asthma]. Pol Arch Med Wewn (1981) 0.75

[Extracorporeal oxygenation in the treatment of respiratory insufficiency]. Pol Arch Med Wewn (1976) 0.75

[Mediators of allergic reactions in asthma in man]. Pol Arch Med Wewn (1979) 0.75

[Function of the pituitary-adrenal axis in bronchial asthma or asthmatic syndromes treated for over 5 years with triamcinolone acetonide]. Pneumonol Pol (1982) 0.75

[Usefulness of a pressurized aerosol inhaler with an elongated mouthpiece]. Pol Arch Med Wewn (1984) 0.75

Cellular immunity in man assessed by indirect migration inhibition test using murine spleen leukocytes. Biomedicine (1973) 0.75

[Salbutamol in the treatment of diseases associated with bronchospasm]. Pol Arch Med Wewn (1972) 0.75

[Intal in the treatment of asthma. III. Long-term treatment of asthma]. Pol Arch Med Wewn (1978) 0.75

[Role of ketotifen in the reduction of corticosteroid doses in steroid-dependent bronchial asthma]. Pol Arch Med Wewn (1984) 0.75

[Clinical evaluation of betamethasone dépôt]. Pneumonol Pol (1982) 0.75

[Advances in the physiopathology, diagnosis and therapy of bronchial asthma]. Pneumonol Pol (1982) 0.75

[Ketotifen--a new anti-asthma drug]. Pol Arch Med Wewn (1980) 0.75

[3-year experience with desensitization of paptients with pollenosis using grass pollen extract of depot type]. Pol Arch Med Wewn (1977) 0.75

[Clinical assessment of Fluimucil in the treatment of respiratory tract infections]. Pneumonol Pol (1976) 0.75

[Lung compliance measurements in chronic lung diseases without recording differences in intrapleural pressure]. Pneumonol Pol (1983) 0.75

[Stability and clinical effectiveness of aminophylline in glucose and isotonic NaCl solution]. Pol Tyg Lek (1983) 0.75

[Clinical evaluation of Intal in the treatment of atopic bronchial asthma (double-blind study)]. Pol Arch Med Wewn (1973) 0.75

[Care of the unconscious patient]. Pieleg Polozna (1970) 0.75

[Editorial: An attempt to define asthma]. Pol Arch Med Wewn (1976) 0.75

[Advances in pulmonology. Lung transplantation]. Pol Arch Med Wewn (1969) 0.75

"The immediate effect of sodium cromoglycate on the airway". Ann Allergy (1983) 0.75

[Results of desensitization with Migen of patients with bronchial asthma caused by hypersensitivity to the mite Dermatophagoides pteronyssinus]. Pneumonol Pol (1978) 0.75

[Role of allergic fungi in respiratory tract diseases]. Pol Arch Med Wewn (1966) 0.75

[Advances in pulmonology. Pulmonary emphysema and other clinical entities connected with congenital absence of alpha-2 antitrypsin in serum]. Pol Arch Med Wewn (1976) 0.75

[Progress in lung diseases]. Pieleg Polozna (1977) 0.75

[Case of megakaryocyte leukemia with an unusual course]. Pol Arch Med Wewn (1978) 0.75

[Bronchospasmolytic agents]. Pol Arch Med Wewn (1979) 0.75

[Functional changes of the respiratory tract in workers of selected departments of the Plock petroleum plants]. Pneumonol Pol (1980) 0.75

[Advances in pulmonology. Bronchial asthma]. Pol Arch Med Wewn (1969) 0.75

Megakaryocytic leukaemia. A case of unusual outcome. Acta Haematol (1978) 0.75

[Long-term home oxygen therapy in obstructive bronchial diseases]. Pol Arch Med Wewn (1983) 0.75

[Diagnostic difficulties in a case of Conn's syndrome]. Endokrynol Pol (1970) 0.75

[Suggestion for classification of diseases correlated with diffuse constriction of the lower respiratory tract]. Pol Arch Med Wewn (1966) 0.75

[Septrin in the treatment of chronic pyelonephritis and certain other bacterial infections. Immediate effect of treatment after short-term administration of the drug]. Pol Arch Med Wewn (1970) 0.75

[Advances in pulmonology. Pneumonia due to mycoplasma]. Pol Arch Med Wewn (1970) 0.75

[What is known today about the immunology and biochemistry of asthma? Immunologic reaction in asthma]. Gruzlica (1974) 0.75

[Adrenergic beta receptor blockaders and bronchial patency]. Pol Arch Med Wewn (1983) 0.75

[Clinical evaluation of aerosol of Polish-made orciprenaline]. Pol Arch Med Wewn (1971) 0.75

[Ketotiphen (Zaditen) in the treatment of asthma]. Pol Arch Med Wewn (1980) 0.75

[Controlled immunotherapy of bronchial asthma]. Pol Tyg Lek (1983) 0.75

[Exercise-induced asthma]. Pol Arch Med Wewn (1982) 0.75

[Advances in pneumonology. Test of small bronchi]. Pol Arch Med Wewn (1978) 0.75

[Nursing of the myocardial infarct patient]. Pieleg Polozna (1970) 0.75

[Triamcinolone acetonide (kenalog) in the treatment of chronic bronchitis and bronchial asthma]. Pol Arch Med Wewn (1972) 0.75

[Advances in pulmonology. Theoretical bases for the use of bronchodilator agents]. Pol Arch Med Wewn (1973) 0.75

[Selected problems of corticotherapy in lung diseases]. Pneumonol Pol (1977) 0.75

[Progress in pneumonology. Legionnaires' disease]. Pol Arch Med Wewn (1982) 0.75